These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 8208268)
21. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis. Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110 [TBL] [Abstract][Full Text] [Related]
22. bcl-6 in lymphoma--sorting out a wastebasket? Kluin PM N Engl J Med; 1994 Jul; 331(2):116-8. PubMed ID: 8208254 [No Abstract] [Full Text] [Related]
23. Prognostic significance of Fas (CD95/APO-1) positivity in patients with primary nodal diffuse large B-cell lymphoma. Eser B; Sari I; Canoz O; Altuntas F; Cakmak E; Ozturk A; Ozkan M; Er O; Cetin M; Unal A Am J Hematol; 2006 May; 81(5):307-14. PubMed ID: 16628716 [TBL] [Abstract][Full Text] [Related]
24. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma. Kramer MH; Hermans J; Wijburg E; Philippo K; Geelen E; van Krieken JH; de Jong D; Maartense E; Schuuring E; Kluin PM Blood; 1998 Nov; 92(9):3152-62. PubMed ID: 9787151 [TBL] [Abstract][Full Text] [Related]
25. Rearrangements of bcl-1, bcl-2, bcl-6, and c-myc in diffuse large B-cell lymphomas. Kawasaki C; Ohshim K; Suzumiya J; Kanda M; Tsuchiya T; Tamura K; Kikuchi M Leuk Lymphoma; 2001; 42(5):1099-106. PubMed ID: 11697627 [TBL] [Abstract][Full Text] [Related]
26. High incidence of BCL-6 gene rearrangement in diffuse large B-cell lymphoma of primary gastric origin. Liang R; Chan WP; Kwong YL; Xu WS; Srivastava G; Ho FC Cancer Genet Cytogenet; 1997 Sep; 97(2):114-8. PubMed ID: 9283593 [TBL] [Abstract][Full Text] [Related]
27. Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma. Lo Coco F; Ye BH; Lista F; Corradini P; Offit K; Knowles DM; Chaganti RS; Dalla-Favera R Blood; 1994 Apr; 83(7):1757-9. PubMed ID: 8142643 [TBL] [Abstract][Full Text] [Related]
28. Bcl-6 gene hypermutations in diffuse large B-cell lymphoma of primary gastric origin. Liang R; Chan WP; Kwong YL; Chan AC; Xu WS; Au WY; Srivastava G; Ho FC Br J Haematol; 1997 Dec; 99(3):668-70. PubMed ID: 9401082 [TBL] [Abstract][Full Text] [Related]
29. MYC cytogenetic status correlates with expression and has prognostic significance in patients with MYC/BCL2 protein double-positive diffuse large B-cell lymphoma. Wang XJ; Medeiros LJ; Lin P; Yin CC; Hu S; Thompson MA; Li S Am J Surg Pathol; 2015 Sep; 39(9):1250-8. PubMed ID: 25828389 [TBL] [Abstract][Full Text] [Related]
30. Prognostic value of bcl-6, CD10 and CD38 immunoreactivity in stage I-II gastric lymphomas: identification of a subset of CD10+ large B-cell lymphomas with a favorable outcome. Ponzoni M; Ferreri AJ; Pruneri G; Pozzi B; Dell'Oro S; Pigni A; Pinotti G; Villa E; Freschi M; Viale G; Capella C Int J Cancer; 2003 Aug; 106(2):288-91. PubMed ID: 12800208 [TBL] [Abstract][Full Text] [Related]
31. Clinical significance of bcl-2-MBR gene rearrangement and protein expression in diffuse large-cell non-Hodgkin's lymphoma: an analysis of 83 cases. Tang SC; Visser L; Hepperle B; Hanson J; Poppema S J Clin Oncol; 1994 Jan; 12(1):149-54. PubMed ID: 8270971 [TBL] [Abstract][Full Text] [Related]
32. ID3 mutations are recurrent events in double-hit B-cell lymphomas. Gebauer N; Bernard V; Feller AC; Merz H Anticancer Res; 2013 Nov; 33(11):4771-8. PubMed ID: 24222112 [TBL] [Abstract][Full Text] [Related]
33. Low incidence of BCL-6 gene alterations for diffuse large B-cell lymphomas in Taiwan Chinese. Chen PM; Yang MH; Yu IT; Lin JT; Lin YC; Fan FS; Wang WS; Yen CC; Chiou TJ; Liu JH Cancer; 2002 May; 94(10):2635-44. PubMed ID: 12173331 [TBL] [Abstract][Full Text] [Related]
34. BCL-6 and other genomic alterations in non-Hodgkin's lymphoma (NHL). Butler M; Corbally N; Dervan PA; Carney DN Br J Cancer; 1997; 75(11):1641-5. PubMed ID: 9184180 [TBL] [Abstract][Full Text] [Related]
35. Rearrangement of the BCL6 locus at 3q27 is an independent poor prognostic factor in nodal diffuse large B-cell lymphoma. Barrans SL; O'Connor SJ; Evans PA; Davies FE; Owen RG; Haynes AP; Morgan GJ; Jack AS Br J Haematol; 2002 May; 117(2):322-32. PubMed ID: 11972514 [TBL] [Abstract][Full Text] [Related]
36. Identification of genetic lesions associated with diffuse large-cell lymphoma. Dalla-Favera R; Ye BH; Lo Coco F; Gaidano G; Lista F; Knowles DM; Louie DC; Offit K; Chaganti RS Ann Oncol; 1994; 5 Suppl 1():55-60. PubMed ID: 8172819 [TBL] [Abstract][Full Text] [Related]
37. [Clinicopathologic features, prognosis and etiology of primary non-Hodgkin lymphoma of bone]. Zhou ZY; Shi QL; Zhou XJ; Lan JY; Wang JD; Huang WB; Chen JY; Ma HH; Zhou HB Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):90-3. PubMed ID: 17493381 [TBL] [Abstract][Full Text] [Related]
39. Bcl-6 protein expression in normal and neoplastic lymphoid tissues. Falini B; Fizzotti M; Pileri S; Liso A; Pasqualucci L; Flenghi L Ann Oncol; 1997; 8 Suppl 2():101-4. PubMed ID: 9209651 [TBL] [Abstract][Full Text] [Related]
40. A recurrent nonrandom translocation (3;7)(q27;p12) associated with BCL-6 gene rearrangement in B-cell diffuse large cell lymphoma. Ichinohasama R; Miura I; Funato T; Sato I; Suzuki C; Saito Y; Decoteau JF; Myers JB; Kadin ME; Sawai T; Ooya K Cancer Genet Cytogenet; 1998 Jul; 104(1):19-27. PubMed ID: 9648553 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]